The proposed mechanism (from the single rat study) is that fadogia's alkaloids and saponins stimulate Leydig cells to produce more testosterone — similar to how LH works. However, the same stimulation appears to damage those cells at effective doses. It's essentially overstimulating the testosterone-producing machinery until it breaks. The alkaloids involved have not been fully characterized, the dose-response curve in humans is completely unknown, and there is no safety margin established.
Insufficient data to classify any interaction as "low-risk" — ALL interactions are unknown.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.